Terns Pharmaceuticals, Inc. (TERN)

34.80 -1.17 (-3.25%) USD  |  NASDAQ  |  Jan 23, 12:20
More

Terns Pharmaceuticals Net Income (Quarterly)

Net Income (Quarterly) Chart

View Net Income (Quarterly) for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Altimmune, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade